Evaluation of pleural disease with FDG-PET imaging

B. C. Duysinx, D. D. Nguyen, R. E. Louis, D. P. Cataldo, T. T. Belhocine, P. P. Bartsch, T. J. Bury (Liege, Belgium)

Source: Annual Congress 2003 - Early lung cancer diagnosis
Session: Early lung cancer diagnosis
Session type: Oral Presentation
Number: 183
Disease area: Thoracic oncology

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. C. Duysinx, D. D. Nguyen, R. E. Louis, D. P. Cataldo, T. T. Belhocine, P. P. Bartsch, T. J. Bury (Liege, Belgium). Evaluation of pleural disease with FDG-PET imaging. Eur Respir J 2003; 22: Suppl. 45, 183

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Integrated FDG PET-CT imaging improves staging in malignant pleural mesothelioma
Source: Eur Respir J 2007; 30: Suppl. 51, 755s
Year: 2007

Utility of FDG-PET in the diagnosis of pulmonary nodules
Source: Eur Respir J 2003; 22: Suppl. 45, 245s
Year: 2003

Comparison of chest x-ray, thoracic computed tomography and 18F-FDG PET/CT for staging of sarcoidosis
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015


The Value of 18F-FDG PET/CT in evaluating disease severity in idiopathic pulmonary fibrosis
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017


Use of integrated FDG PET/CT imaging in sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 542s
Year: 2006

CT and FDG PET/CT findings of pulmonary involvement in methotrexate-associated lymphoproliferative disease
Source: International Congress 2018 – CC6 Interstitial lung diseases
Year: 2018


Use of integrated FDG PET/CT imaging in pulmonary cacinoid tumors
Source: Eur Respir J 2006; 28: Suppl. 50, 775s
Year: 2006

Relevance of FDG-PET-CT scan for the evaluation of local pleural invasion assessed by thoracoscopy in malignant pleural mesothelioma
Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions
Year: 2012


The usefulness of dynamic CT and 18F-FDG PET to distinguish between benignancy and malignancy in solitary pulmonary nodule
Source: Eur Respir J 2007; 30: Suppl. 51, 532s
Year: 2007

Incidental extra pulmonary abnormalities in positive emission tomography imaging with fluro-deoxyglucose done for lung cancer staging
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008


Pleural imaging: CT scan and MRI
Source: School Course 2014 - Thoracoscopy and Pleural Techniques
Year: 2014

Pleural imaging: CT scan and MRI
Source: ERS Course 2015
Year: 2015

The Role of PET-CT in differential diagnosis of malignant-paramalignant pleural effusion
Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma
Year: 2018

Diagnostic yield of computed tomography for idiophatic pleural effusions
Source: Eur Respir J 2006; 28: Suppl. 50, 774s
Year: 2006

HRCT imaging vs chest-x-ray assessment of endothoracal sarcoidosis extent
Source: Eur Respir J 2006; 28: Suppl. 50, 676s
Year: 2006

Emerging diagnostics from MRI, PET and CT studies of lung disease
Source: Virtual Congress 2021 – Emerging imaging biomarkers in lung disease
Year: 2021


Assessment with STIR MR imaging and PET-CT for malignant or benign lesion in the mediastinal and hilar lymph nodes
Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques
Year: 2007



Imaging of malignant pleural mesothelioma with fluordeoxyglucose positron emission tomography (FDG-PET)
Source: Eur Respir J 2001; 18: Suppl. 33, 396s
Year: 2001

Cytology, chest computed and positron emission tomography correlations in lung cancer malignant pleural effusion.
Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management
Year: 2018